Gujarat Themis Biosyn Limited Stock Price

BSE:506879 Community·₹32.2b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

506879 Share Price Performance

₹295.45

58.40 (24.64%)

₹295.45

58.40 (24.64%)

₹295.45

Tue, 3 Mar 26

Share Pricen/a

506879 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Adequate balance sheet with questionable track record.

0 Risks

0 Rewards

View Full Analysis

Gujarat Themis Biosyn Limited Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 4.39
: 62.34%
: 29.99%
: 27.0%

View Full Analysis

About 506879

Founded: 1981
Employees: 221
CEO: Sachin Patel
WebsiteView website: www.gtbl.in

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.